| abstract |
The present invention provides agents for treating or preventing diseases such as mood disorder, anxiety disorder, schizophrenia, Alzheimer's disease, Parkinson's disease, Huntington's chorea, eating disorders, hypertension, gastrointestinal disease, drug addiction , epilepsy, cerebral infarction, cerebral ischemia, cerebral edema, head injury, inflammation, diseases related to immunity, alopecia and so on; specifically, the invention provides azol derivatives represented by the general formula (I), or pharmaceutically acceptable salts thereof that have an antagonistic action against the arginine vasopressin V1b receptor (AVP): Chem. 1 (see Formula). |